Home » Topics » Regulatory » Patents

Patents
RSS

NK1 antagonists described by Boehringer Ingelheim

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Therapeutically active cysteine proteinase inhibitors described by Synphar

Dec. 13, 1996

New antitumor agents from Kyowa Hakko

Dec. 12, 1996

Mitsubishi Chemical isolates novel antitumor agent from plant source

Dec. 12, 1996

Daiichi claims LTD4 antagonists for treating allergic diseases

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Novel dual-action compounds described by Abbott

Dec. 12, 1996

NOS inhibitors described by Searle

Dec. 12, 1996

MMP/TNF inhibitors reported by Pfizer

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...